Acute myeloid leukemia with myeloid sarcoma and eosinophilia: prolonged remission and molecular response to imatinib.
Védy
Dana
D
Service et Laboratoire Central d'Hématologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Muehlematter
Dominique
D
Rausch
Thierry
T
Stalder
Michèle
M
Jotterand
Martine
M
Spertini
Olivier
O
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D004802:Eosinophilia / Q000209:etiology; D006801:Humans; D000068877:Imatinib Mesylate; D015470:Leukemia, Myeloid, Acute / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D012074:Remission Induction; D023981:Sarcoma, Myeloid / Q000209:etiology
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate